Johnson & Johnson reported a 73% PSA response rate in a 15-patient Phase 1 trial of its dual bispecific antibody combo for ...
First-of-its-kind dual-antigen-targeted bispecific regimen of pasritamig and JNJ-9401 directed at two prostate cancer proteins, KLK2 and PSMA, using complementary signals to activate T cells against ...
A comprehensive review published in Genes and Environment examines the complex relationship between tobacco smoking and ...
Shankar Siva, MBBS, PhD, FRANZCR, discussed when to consider cytoreductive SABR in patients with metastatic kidney cancer ...
A review in Biological Research details how telomerase-targeted therapies, including imetelstat and peptide vaccines, are ...
Cancer cells carry traces of the processes that damaged their DNA. By studying those traces across 24 types of cancer, ...
Thousands of men with advanced prostate cancer will be offered a new treatment, Pfizer's Talzenna, from today after NICE made an about-turn on the drug. The reimbursement authority said last year that ...
Are We Treating Metastatic Prostate Cancer Earlier, or Overtreating Patients Sooner? / Alessandro Rossi, Angelo Di Giorgio, ...
Juventus returns to the field in Serie A. Today, Sunday, November 8, Spalletti's team faces Fiorentina - live on TV and streaming - at the Artemio Franchi, in the big match that closes the eleventh ...
Milan returns to the field in Serie A. Today, Sunday, November 8, the Rossoneri face Genoa - live on TV and streaming - in Marassi, on the eleventh matchday of the championship. Amorim's team, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results